Cardio Diagnostics Holdings, Inc. Capital Expenditures
Cardio Diagnostics Holdings, Inc. (CDIO) reported Capital Expenditures of $1.76 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $1.76K, a 69.59% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $162.83K, a 600.48% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $187.32K, a 12.78% decline from fiscal 2024.
- Cardio Diagnostics Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $214.76K, a 62.69% decline from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $575.66K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.76K 10-Q · filed 2026-08-07 | $1.76K derived: sum of 3 quarters · filed 2026-08-07 | $164.59K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.76K 10-Q · filed 2026-05-15 | $1.76K derived: sum of 2 quarters · filed 2026-05-15 | $164.59K derived: sum of 3 quarters · filed 2026-05-15 | $183.29K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $162.83K derived: sum of 2 quarters · filed 2026-03-13 | $181.53K derived: sum of 3 quarters · filed 2026-08-07 | $187.32K 10-K · filed 2026-03-13 |
| 2025-09-30 | $162.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $181.53K derived: sum of 2 quarters · filed 2026-08-07 | $187.32K 10-Q · filed 2025-11-12 | $190.96K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $18.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $24.48K 10-Q · filed 2026-08-07 | $28.12K derived: sum of 3 quarters · filed 2026-08-07 | $51.37K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $5.79K 10-Q · filed 2026-05-15 | $9.43K derived: sum of 2 quarters · filed 2026-05-15 | $32.67K derived: sum of 3 quarters · filed 2026-05-15 | $200.57K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $3.64K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $26.88K derived: sum of 2 quarters · filed 2026-03-13 | $194.78K derived: sum of 3 quarters · filed 2026-03-13 | $214.76K 10-K · filed 2026-03-13 |
| 2024-09-30 | $23.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $191.14K derived: sum of 2 quarters · filed 2025-11-12 | $211.13K 10-Q · filed 2025-11-12 | $748.18K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $167.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $187.88K 10-Q · filed 2025-08-14 | $724.93K derived: sum of 3 quarters · filed 2025-08-14 | $737.52K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $19.98K 10-Q · filed 2025-05-15 | $557.04K derived: sum of 2 quarters · filed 2025-05-15 | $569.63K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $537.05K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $549.64K derived: sum of 2 quarters · filed 2025-03-20 | $575.66K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $12.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $38.61K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $26.02K 10-Q · filed 2024-08-12 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |